---
title: "RA Capital Management files initial beneficial ownership statement in Inhibikase Therapeutics"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293077513.md"
description: "RA Capital Management filed a Form 3 with the SEC, disclosing beneficial ownership of 25 million common shares in Inhibikase Therapeutics. The filing identifies RA Capital as a 10% owner through indirect ownership. The event occurred on July 10, 2026, and the statement was dated July 17, 2026."
datetime: "2026-07-17T21:55:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293077513.md)
  - [en](https://longbridge.com/en/news/293077513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293077513.md)
---

# RA Capital Management files initial beneficial ownership statement in Inhibikase Therapeutics

-   RA Capital Management filed a Form 3 showing beneficial ownership of 25 million Inhibikase Therapeutics common shares. \* The filing lists RA Capital as a 10% owner, with the position reported as indirect ownership. \* The event date was July 10, 2026; the statement was signed and dated July 17, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibikase Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000769), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IKT.US](https://longbridge.com/en/quote/IKT.US.md)

## Related News & Research

- [Inhibikase rugi bersih Q2 FY26 melebar jadi USD 19,6 juta; belanja R&D melonjak 153,9% jadi USD 13,4 juta](https://longbridge.com/en/news/295574378.md)
- [Inhibikase Therapeutics Faces Rising BIOSECURE, China Supply Chain and Trial Risks That Could Disrupt Growth](https://longbridge.com/en/news/295752640.md)
- [Apollo Global Management files Form 3 initial beneficial ownership statement for LDB 2025 LLC](https://longbridge.com/en/news/295974245.md)
- [Freedom Holding files Form 3 as Chief Logistics Officer Marat Shotbayev reports 252 shares stake](https://longbridge.com/en/news/295924722.md)
- [Illumina ajukan Form 3; Chief Legal Officer Julie Ann Coletti laporkan kepemilikan manfaat awal](https://longbridge.com/en/news/295576352.md)